Profound Medical Corp

PRN NPV
Create an alert
Sell8.10 CAD
Buy8.44 CAD
0.15 CAD (1.75%)
Last updated today at
Back to dashboard

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
17 September 2026
Richard Ringler FabianPresident
Buy
Regular purchase transaction
10,000$5.98$59,800.0010,000
11 September 2026
Arun Swarup MenawatChairman/CEO
Sell
Tax related
4,2039.39 CAD39,466.17 CAD745,678
11 September 2026
Brian Robert EllacottDirector
Sell
Tax related
9279.39 CAD8,704.53 CAD72,704
11 September 2026
Arthur Lee RosenthalDirector
Sell
Tax related
7819.39 CAD7,333.59 CAD61,848
11 September 2026
Mathieu BurtnykSenior Vice President
Sell
Tax related
3,6979.39 CAD34,714.83 CAD58,212
11 September 2026
Murielle LortieDirector
Sell
Tax related
9279.39 CAD8,704.53 CAD7,853
11 September 2026
Matthew SobczykCFO
Sell
Tax related
4089.39 CAD3,831.12 CAD1,327
17 August 2026
Thomas Michael (Tom) TamberrinoChief Level Officer
Buy
Regular purchase transaction
3,755$6.69$25,137.4753,573
24 June 2026
Arun Swarup MenawatChairman/CEO
Sell
Tax related
25,4469.27 CAD235,884.42 CAD733,214
24 June 2026
Rashed Osman DewanCFO
Sell
Tax related
8,8739.27 CAD82,252.71 CAD86,119

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
24 June 2026
Arun Swarup MenawatChairman/CEO
Sell
Tax related
25,4469.27 CAD235,884.42 CAD733,214
24 June 2026
Mathieu BurtnykSenior Vice President
Sell
Tax related
13,3079.27 CAD123,355.89 CAD55,242
20 March 2026
Arun Swarup MenawatChairman/CEO
Buy
Regular purchase transaction
20,000$5.10$101,922.00658,660
23 December 2025
Arthur Lee RosenthalDirector
Buy
Regular purchase transaction
13,900$7.30$101,470.0058,841
23 December 2025
Arun Swarup MenawatChairman/CEO
Buy
Regular purchase transaction
13,396$7.47$100,001.14638,660

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.